Insider
Innovations in Care
Innovator CEO profile: SomaLogic’s Roy Smythe
Powered by SomaLogic
In this Innovation Lab interview series, Smythe discusses SomaLogic’s origin story, the potential of proteomics for precision health, what’s next for the company and more.
Health Equity
Why one life sciences company is investing $100 million in a social impact fund
Edwards Lifesciences has unveiled an initiative that aims to advance racial equity in underserved communities. CFO Scott Ullem talked with us about why the company went this route.
Read More
Innovations in Care
What it will take to maintain the accelerated pace of innovation in health care post-pandemic
Executives from HCA Healthcare, SCAN Group and Health Plan, Aledade and ChenMed discuss what leaders and policy makers need to do to continue the current pace of change in the industry.
Read More
Health Equity
HHS Asst. Secretary Rachel Levine: LGBTQ+ people are not invisible under the Biden-Harris Administration
Levine says that health equity is a top priority of the Biden-Harris administration, particularly in light of COVID-related challenges. She spoke with Health Evolution about specific efforts regarding SOGI data and inter-agency collaboration.
Read More
M&A
Video: Policy insiders discuss health care consolidation and change management
At the Health Evolution Summit, federal and state policy leaders went into depth about what kind of impact increased M&A activity in health care might have on care coordination.
Read More
Medical Breakthroughs
Can genomics help address the cancer screening crisis?
Fewer patients are getting screened for cancer as a result of the pandemic. CancerIQ Founder & CEO Feyi Olopade Ayodele says that genomics-based screening assessments can provide health systems with a path forward to more effective cancer prevention.
Read More
Health Equity
Health Equity Roadmap: How CEOs can take a methodical approach to addressing health disparities
Health Evolution Forum Fellows participating in the Work Group on Leveraging Data to Improve Health Equity have created a new guide outlining actionable steps that health care CEOs can take to advance health equity on an enterprise level.
Read More
Medical Breakthroughs
Eli Lilly, Takeda, Verily executives on how COVID set the stage for a new era of drug development
David Ricks, CEO of Eli Lilly, Christophe Weber, CEO of Takeda, Amy Abernethy, MD, PhD, President of Verily’s Clinical Studies Platforms, and Chris Toth, CEO of Varian, discussed how COVID has opened the door for faster drug development and improved clinical trials.
Read More
Leadership
Early lessons from CEOs who required vaccines before Biden’s mandate
The CEOs of ChristianaCare, GuideWell & Florida Blue, Henry Ford, Jefferson Health, Kaiser Permanente and public health experts discuss their experience leading efforts to inoculate their workforce — when many people have been against required vaccination.
Read More
Leadership
Health execs on the move: Wheeler retires, Feinberg moves to Cerner, Paz heads east, Gorsky departs J&J
In this volume of Health execs on the move, Penny Wheeler, MD and Hal Paz, MD are leaving their CEO roles at Midwestern health systems; David Feinberg, MD is headed to Cerner; and Alex Gorsky, CEO of J&J, is departing the pharma giant.
Read MoreHealth Evolution Insider
Sign up for weekly insights and interviews with top CEO-level leaders and more
Insights
